1. Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform. Issue 1 (2nd January 2018) Authors: MacDonald, Lisa D.; MacKay, Alecia; Kaliaperumal, Valarmathy; Weir, Genevieve; Penwell, Andrea; Rajagopalan, Rajkannan; Langley, Joanne M.; Halperin, Scott; Mansour, Marc; Stanford, Marianne M. Journal: Human vaccines & immunotherapeutics Issue: Volume 14:Issue 1(2018) Page Start: 59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗